You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PALBO

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Real-World Evidence In Patients Treated With Palbociclib

Recruiting
  • Metastatic Breast Cancer
  • Timisoara, Timiș, Romania
  • +5 more
Dec 7, 2022

HER2-positive Breast Cancer, Breast Cancer, Breast Cancer Stage Trial in United States (Palbociclib, T-DM1)

Completed
  • HER2-positive Breast Cancer
  • +5 more
  • Tucson, Arizona
  • +15 more
Dec 22, 2022

Solid Tumors, NSCLC, CRC Trial in United States (Telaglenestat (CB-839), Palbociclib Oral Capsule or Tablet [Ibrance])

Completed
  • Solid Tumors
  • +3 more
  • Telaglenestat (CB-839)
  • Palbociclib Oral Capsule or Tablet [Ibrance]
  • Santa Monica, California
  • +9 more
Sep 14, 2022

Breast Tumors Trial in Italy (Trastuzumab, Pertuzumab, Palbociclib)

Completed
  • Breast Neoplasms
  • Bologna, BO, Italy
  • +6 more
Jul 14, 2020

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Germany (Palbociclib)

Unknown status
  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Augsburg, Germany
  • +23 more
Apr 11, 2019

Metastatic Breast Cancer, Locally Advanced Breast Cancer Trial in Italy (Palbociclib)

Recruiting
  • Metastatic Breast Cancer
  • Locally Advanced Breast Cancer
  • Prato, Firenze, Italy
  • +18 more
Mar 20, 2020

Breast Cancer Stage IV Trial in Seoul (tissue biopsy, blood sample)

Recruiting
  • Breast Cancer Stage IV
  • tissue biopsy, blood sample
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 15, 2018